MONIKA WOŁOSIK; NATALIA BEDNARCZYK; RAFAŁ BEDNARCZYK; RADOSŁAW KRZYSZTOF BINKOWSKI; AGNIESZKA KUREK; NATALIA KRAJEWSKA; ALEKSANDRA LEJMAN; ALEKSANDRA MAZURKIEWICZ; HUBERT SIDOR; SZYMON ZYSIAK. COBENFY (XANOMELINE-TROSPIUM CHLORIDE) AS A BREAKTHROUGH IN SCHIZOPHRENIA TREATMENT: POTENTIAL IMPACT ON PATIENT QUALITY OF LIFE AND HEALTHCARE ECONOMICS. International Journal of Innovative Technologies in Social Science, n. 1(49), 17 Jan. 2026.